Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Is hypertension an inflammatory process?

Christopher J Boos1, Gregory Y H Lip

  • 1Haemostasis, Thrombosis and Vascular Biology Unit, University Department of Medicine, City Hospital, Birmingham B18 7QH, England, UK.

Current Pharmaceutical Design
|May 30, 2006
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Mediating factors in the relationship between combat-related traumatic injury and myocardial blood flow reserve: The ADVANCE cohort study.

PloS one·2026
Same author

Knee osteoarthritis in the intact- and amputation-side knees of UK military personnel and veterans with traumatic unilateral transtibial limb loss 8- and 11-years post-injury: the ADVANCE cohort.

Archives of physical medicine and rehabilitation·2026
Same author

Biases in the measurement of health-related quality of life in the EQ-5D-5L among those with serious physical traumatic injuries: the ADVANCE cohort study.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2026
Same author

Influence of major trauma and lower limb loss on radiographic progression and incidence of knee osteoarthritis and pain: a comparative and predictive analysis from the ADVANCE study.

Arthritis research & therapy·2026
Same author

Multidimensional qualities of sleep health following serious physical combat injuries: A Latent Class Analysis: The ADVANCE cohort study.

Sleep medicine·2025
Same author

Acute Eosinophilic Myocarditis and Heart Failure As the First Manifestation of Eosinophilic Granulomatosis With Polyangiitis (EGPA) in an Asthmatic Patient: A Diagnostic Challenge.

Cureus·2025
Same journal

Fentanyl and its Analogs: A Medicinal Chemistry Perspective on Therapeutic Potential and Abuse Liability.

Current pharmaceutical design·2026
Same journal

Acne Vulgaris: Integrating Pathophysiology with Conventional, Herbal, and Nanocarrier-Based Therapeutic Strategies.

Current pharmaceutical design·2026
Same journal

Systems Pharmacology and Pharmaco-Transcriptomic Insights into Bauhinia variegata for Polycystic Ovary Syndrome Management.

Current pharmaceutical design·2026
Same journal

Curcumin and Cognitive Health: Insights from Randomized Controlled Trials.

Current pharmaceutical design·2026
Same journal

Inorganic Materials-integrated Porphyrin for Drug Delivery in Cancer Therapy: Promises, Challenges and Outlooks.

Current pharmaceutical design·2026
Same journal

Precision Nanotechnology in Oral Oncology: From Biomarker-Guided Targeting to AI-Driven Theranostics.

Current pharmaceutical design·2026
See all related articles

Chronic low-grade inflammation is increasingly recognized as a factor in hypertension development. Targeting inflammation offers a potential new strategy for preventing and treating high blood pressure.

Area of Science:

  • Cardiovascular Medicine
  • Immunology
  • Pharmacology

Background:

  • Hypertension risk factors are incompletely understood, limiting current prevention and drug development.
  • Chronic low-grade inflammation is implicated in vascular disease pathogenesis and may contribute to hypertension.
  • Elevated pro-inflammatory markers like high-sensitivity C-reactive protein (hsCRP) are observed in hypertensive patients.

Purpose of the Study:

  • To explore the role of inflammation in hypertension development and pathogenesis.
  • To investigate the predictive value of inflammatory markers for hypertension.
  • To assess the potential of anti-inflammatory therapies in hypertension management.

Main Methods:

  • Review of clinical studies examining inflammatory markers (e.g., hsCRP) in hypertensive, prehypertensive, and normotensive individuals.

Related Experiment Videos

  • Pathophysiological analysis of inflammation's impact on endothelial function, arterial stiffness, nitric oxide (NO) availability, and oxidative stress.
  • Examination of evidence for anti-inflammatory properties of existing hypertension medications.

    • Main Results:

    • Increased hsCRP levels are associated with hypertension and predict its development.
    • Inflammation contributes to endothelial dysfunction and arterial stiffness in hypertension, linked to reduced nitric oxide (NO) availability and oxidative stress.
    • Common antihypertensive drugs (statins, ACE inhibitors, ARBs) exhibit anti-inflammatory effects.

    Conclusions:

    • Inflammation is a significant factor in hypertension pathogenesis.
    • Targeting inflammation presents a promising therapeutic avenue for hypertension.
    • Further research into anti-inflammatory strategies could lead to novel drug development for hypertension management.